메뉴 건너뛰기




Volumn 4, Issue , 2010, Pages 115-125

One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects

Author keywords

Adherence; EFV FTC TDF; Once daily antiretroviral regimen; Patient preferences; QoL; Single pill regimen

Indexed keywords


EID: 77954618054     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (162)

References (36)
  • 1
    • 0030889653 scopus 로고    scopus 로고
    • Compliance with treatment regimens in chronic asymptomatic diseases
    • Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med. 1997;102:43-49.
    • (1997) Am J Med , vol.102 , pp. 43-49
    • Miller, N.H.1
  • 2
    • 0032543545 scopus 로고    scopus 로고
    • Virological failure and adherence to antiretroviral therapy in HIV-infected patients
    • Rodriguez-Rosado R, Jimenez-Nacher I, Soriano V, et al. Virological failure and adherence to antiretroviral therapy in HIV-infected patients. AIDS. 1998;12:1112-1113.
    • (1998) AIDS , vol.12 , pp. 1112-1113
    • Rodriguez-Rosado, R.1    Jimenez-Nacher, I.2    Soriano, V.3
  • 3
    • 0041827389 scopus 로고    scopus 로고
    • High levels of adherence do not prevent accumulation of HIV drug resistance mutations
    • Bangsberg DR, Charlebois ED, Grant RM, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003;17:1925-1932.
    • (2003) AIDS , vol.17 , pp. 1925-1932
    • Bangsberg, D.R.1    Charlebois, E.D.2    Grant, R.M.3
  • 4
    • 0034604276 scopus 로고    scopus 로고
    • Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
    • Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
    • (2000) Ann Intern Med , vol.133 , pp. 21-30
    • Paterson, D.L.1    Swindells, S.2    Mohr, J.3
  • 5
    • 11144236109 scopus 로고    scopus 로고
    • Similar adherence rates favour different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors
    • Maggiolo F, Ravasio L, Ripamonti D, et al. Similar adherence rates favour different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis. 2005;40:158-163.
    • (2005) Clin Infect Dis , vol.40 , pp. 158-163
    • Maggiolo, F.1    Ravasio, L.2    Ripamonti, D.3
  • 6
    • 33748642352 scopus 로고    scopus 로고
    • Less than 95% adherence to nonnucleoside reverse transcriptase inhibitor therapy can lead to viral suppression
    • Bangsberg D. Less than 95% adherence to nonnucleoside reverse transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43:939-941.
    • (2006) Clin Infect Dis , vol.43 , pp. 939-941
    • Bangsberg, D.1
  • 7
    • 34247249920 scopus 로고    scopus 로고
    • Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India
    • Shah B, Walshe L, Saple DG, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44:1235-1244.
    • (2007) Clin Infect Dis , vol.44 , pp. 1235-1244
    • Shah, B.1    Walshe, L.2    Saple, D.G.3
  • 8
    • 36048981531 scopus 로고    scopus 로고
    • Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients
    • Maggiolo F, Airoldi M, Kleinloog HD, et al. Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients. HIV Clin Trials. 2007;8:282-292.
    • (2007) HIV Clin Trials. , vol.8 , pp. 282-292
    • Maggiolo, F.1    Airoldi, M.2    Kleinloog, H.D.3
  • 9
    • 33646034630 scopus 로고    scopus 로고
    • Adherence-resistance relationship for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness
    • Bangsberg DR, Acosta EP, Gupta R, et al. Adherence-resistance relationship for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20:223-231.
    • (2006) AIDS. , vol.20 , pp. 223-231
    • Bangsberg, D.R.1    Acosta, E.P.2    Gupta, R.3
  • 10
    • 3042842610 scopus 로고    scopus 로고
    • Modelling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates
    • Bangsberg DR, Porco TC, Kagay C, et al. Modelling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates. J Infect Dis. 2004;190:162-165.
    • (2004) J Infect Dis , vol.190 , pp. 162-165
    • Bangsberg, D.R.1    Porco, T.C.2    Kagay, C.3
  • 11
    • 0035146653 scopus 로고    scopus 로고
    • Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS Cohort Study
    • Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82-92.
    • (2001) J Acquir Immune Defic Syndr , vol.26 , pp. 82-92
    • Kleeberger, C.A.1    Phair, J.P.2    Strathdee, S.A.3
  • 12
    • 0033391009 scopus 로고    scopus 로고
    • Sociodemographic and psycological variables influencing adherence to antiretroviral therapy
    • Gordillo V, del Amo J, Soriano V, et al. Sociodemographic and psycological variables influencing adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 1999;13:1763-1769.
    • (1999) J Acquir Immune Defic Syndr , vol.13 , pp. 1763-1769
    • Gordillo, V.1    del Amo, J.2    Soriano, V.3
  • 13
    • 33846628608 scopus 로고    scopus 로고
    • Adherence in antiretroviral therapy: A review of qualitative studies
    • Vervoort SCJM, Borleffs JCC, Hoepelman AIM, et al. Adherence in antiretroviral therapy: a review of qualitative studies. AIDS. 2007;21:271-281.
    • (2007) AIDS , vol.21 , pp. 271-281
    • Vervoort, S.C.J.M.1    Borleffs, J.C.C.2    Hoepelman, A.I.M.3
  • 14
    • 0036749951 scopus 로고    scopus 로고
    • Simpler regimens may enhance adherence to antiretrovirals in HIV infected patients
    • Maggiolo F, Ripamonti D, Arici C, et al. Simpler regimens may enhance adherence to antiretrovirals in HIV infected patients. HIV Clin Trials. 2002;5:371-378.
    • (2002) HIV Clin Trials , vol.5 , pp. 371-378
    • Maggiolo, F.1    Ripamonti, D.2    Arici, C.3
  • 15
    • 0038555460 scopus 로고    scopus 로고
    • Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than those receiving protease inhibitor-containing regimens
    • Trotta MP, Ammassari A, Cozzi-Lepri A, et al. Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than those receiving protease inhibitor-containing regimens. AIDS. 2003;17: 1099-1102.
    • (2003) AIDS , vol.17 , pp. 1099-1102
    • Trotta, M.P.1    Ammassari, A.2    Cozzi-Lepri, A.3
  • 16
    • 0036615658 scopus 로고    scopus 로고
    • Adherence to antiretroviral therapy and outcomes in HIV infected patients enrolled in an induction/ maintenance randomized trial
    • Flandre P, Peytavin G, Meifreddy V, et al. Adherence to antiretroviral therapy and outcomes in HIV infected patients enrolled in an induction/ maintenance randomized trial. Antivir Ther. 2002;7:113-121.
    • (2002) Antivir Ther , vol.7 , pp. 113-121
    • Flandre, P.1    Peytavin, G.2    Meifreddy, V.3
  • 17
    • 3042775345 scopus 로고    scopus 로고
    • Perspectives on adherence and simplicity of HIV-infected patients on antiretroviral therapy. Self-report of the relative importance of multiple attributes of Highly Active Antiretroviral Therapy (HAART) regimens in predicting adherence
    • Stone VE, Jordan J, Tolson J, et al. Perspectives on adherence and simplicity of HIV-infected patients on antiretroviral therapy. Self-report of the relative importance of multiple attributes of Highly Active Antiretroviral Therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr. 2004;36:808-816.
    • (2004) J Acquir Immune Defic Syndr , vol.36 , pp. 808-816
    • Stone, V.E.1    Jordan, J.2    Tolson, J.3
  • 18
    • 45949108248 scopus 로고    scopus 로고
    • Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus more frequent regimen improves adherence while maintaining viral suppression
    • Boyle B, Jayaweera D, Witt MD, et al. Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus more frequent regimen improves adherence while maintaining viral suppression. HIV Clin Trials. 2008;9:164-176.
    • (2008) HIV Clin Trials , vol.9 , pp. 164-176
    • Boyle, B.1    Jayaweera, D.2    Witt, M.D.3
  • 19
    • 0033496346 scopus 로고    scopus 로고
    • Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy
    • Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29:824-830.
    • (1999) Clin Infect Dis , vol.29 , pp. 824-830
    • Singh, N.1    Berman, S.M.2    Swindells, S.3
  • 20
    • 37349036469 scopus 로고    scopus 로고
    • HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time
    • Holmes WC, Bilker WB, Wang H, et al. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr. 2007;46:323-327.
    • (2007) J Acquir Immune Defic Syndr , vol.46 , pp. 323-327
    • Holmes, W.C.1    Bilker, W.B.2    Wang, H.3
  • 21
    • 10244222219 scopus 로고    scopus 로고
    • A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV
    • Benson CA, van der Horst C, LaMarca A, et al. A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. AIDS. 2004;18:2269-2276.
    • (2004) AIDS , vol.18 , pp. 2269-2276
    • Benson, C.A.1    van der Horst, C.2    LaMarca, A.3
  • 22
    • 0027569430 scopus 로고
    • The MOS 36-Item Short-Form Health Survey (SF-36) Psychometric and clinical tests of validity in measuring physical and mental health constructs
    • McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36) Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.
    • (1993) Med Care , vol.31 , pp. 247-263
    • McHorney, C.A.1    Ware Jr., J.E.2    Raczek, A.E.3
  • 23
    • 0020574134 scopus 로고
    • Studies with different types of visual analogue scales for measurement of pain
    • Sriwatanakul K, Kelvie W, Lasagna L, et al. Studies with different types of visual analogue scales for measurement of pain. Clin Pharmacol Ther. 1983;34:234-239.
    • (1983) Clin Pharmacol Ther , vol.34 , pp. 234-239
    • Sriwatanakul, K.1    Kelvie, W.2    Lasagna, L.3
  • 24
    • 2542565696 scopus 로고    scopus 로고
    • Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale
    • Giordano TP, Guzman D, Clark R, et al. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74-79.
    • (2004) HIV Clin Trials , vol.5 , pp. 74-79
    • Giordano, T.P.1    Guzman, D.2    Clark, R.3
  • 25
    • 12144288676 scopus 로고    scopus 로고
    • Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients
    • Clotet B, Carmena J, Pulido F, et al. Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients. HIV Clin Trials. 2004; 5:33-39.
    • (2004) HIV Clin Trials , vol.5 , pp. 33-39
    • Clotet, B.1    Carmena, J.2    Pulido, F.3
  • 26
    • 0345458936 scopus 로고
    • 1993 revised system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention. 1993 revised system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 1992;41:9-12.
    • (1992) MMWR , vol.41 , pp. 9-12
  • 27
    • 33645103497 scopus 로고    scopus 로고
    • Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients
    • The Swiss HIV Cohort study
    • Glass TR, De Geest S, Weber R, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients. The Swiss HIV Cohort study. J Acquir Immune Defic Syndr. 2006;41:385-392.
    • (2006) J Acquir Immune Defic Syndr , vol.41 , pp. 385-392
    • Glass, T.R.1    De Geest, S.2    Weber, R.3
  • 28
    • 0033773461 scopus 로고    scopus 로고
    • The concept of clinically meaningful in healthrelated quality-of-life research. How meaningful is it?
    • Hays RD, Woolley JM. The concept of clinically meaningful in healthrelated quality-of-life research. How meaningful is it? Pharmacoeconomics. 2000;18:419-423.
    • (2000) Pharmacoeconomics , vol.18 , pp. 419-423
    • Hays, R.D.1    Woolley, J.M.2
  • 29
    • 52049088798 scopus 로고    scopus 로고
    • Antiretroviral failure despite high levels of adherence: Discordant adherence-response relationship in Botswana
    • Bisson GP, Rowh A, Weinstein R, et al. Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana. J Acquir Immune Defic Syndr. 2008;49:107-110.
    • (2008) J Acquir Immune Defic Syndr , vol.49 , pp. 107-110
    • Bisson, G.P.1    Rowh, A.2    Weinstein, R.3
  • 30
    • 33745466408 scopus 로고    scopus 로고
    • A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART
    • Golin CE, Earp J, Tien HC, et al. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42:42-51.
    • (2006) J Acquir Immune Defic Syndr , vol.42 , pp. 42-51
    • Golin, C.E.1    Earp, J.2    Tien, H.C.3
  • 31
    • 0035894169 scopus 로고    scopus 로고
    • Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection
    • Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001;28:445-449.
    • (2001) J Acquir Immune Defic Syndr , vol.28 , pp. 445-449
    • Ammassari, A.1    Murri, R.2    Pezzotti, P.3
  • 32
    • 0036798791 scopus 로고    scopus 로고
    • Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy
    • Heath KV, Singer J, O'Shaughnessy MV, et al. Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:211-217.
    • (2002) J Acquir Immune Defic Syndr , vol.31 , pp. 211-217
    • Heath, K.V.1    Singer, J.2    O'Shaughnessy, M.V.3
  • 33
    • 40749143163 scopus 로고    scopus 로고
    • Mild-to moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals
    • Mannheimer SB, Wold N, Gardner EM, et al. Mild-to moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clin Infect Dis. 2008;46:941-945.
    • (2008) Clin Infect Dis , vol.46 , pp. 941-945
    • Mannheimer, S.B.1    Wold, N.2    Gardner, E.M.3
  • 34
    • 46049096485 scopus 로고    scopus 로고
    • Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
    • Shen L, Peterson S, Sedaghat AR, et al. Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. Nat Med. 2008;14:762-766.
    • (2008) Nat Med , vol.14 , pp. 762-766
    • Shen, L.1    Peterson, S.2    Sedaghat, A.R.3
  • 35
    • 67649185287 scopus 로고    scopus 로고
    • Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients
    • DeJesus E, Young B, Morales-Ramirez JO, et al. Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients. J Acquir Immune Defic Syndr. 2009;51:163-174.
    • (2009) J Acquir Immune Defic Syndr , vol.51 , pp. 163-174
    • DeJesus, E.1    Young, B.2    Morales-Ramirez, J.O.3
  • 36
    • 37349036469 scopus 로고    scopus 로고
    • HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time
    • Holmes WC, Bilker WB, Wang H, et al. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr. 2007;46:323-327.
    • (2007) J Acquir Immune Defic Syndr , vol.46 , pp. 323-327
    • Holmes, W.C.1    Bilker, W.B.2    Wang, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.